A Clearer Lens on Modern Diagnostics
Medical technology often advances in incremental steps, but occasionally an idea emerges that fundamentally alters how we view the human body. For over a century, the standard X-ray has been the foundational workhorse of triage and diagnostics. It is fast, universally available, and cheap. Yet it has a glaring historical limitation: it struggles to separate overlapping structures. A dense bone can easily hide a tiny, early-stage lung nodule, a faint hairline fracture, or a critically misplaced bedside line.
For decades, the only way to bypass this limitation was to upgrade to a Computed Tomography (CT) scan. While CT scans offer immaculate, cross-sectional clarity, they come with substantial trade-offs. They require massive, expensive infrastructure, expose patients to significantly higher doses of radiation, and cannot be brought easily to a critical patient’s bedside. This stark divide between the accessibility of an X-ray and the clarity of a CT scan has long been an accepted compromise in global medicine.
The Blind Spots in Conventional Radiography
In a busy emergency room or intensive care unit, timing and clarity are everything. When a physician orders a standard chest X-ray, the resulting image collapses a three-dimensional human torso into a single, flat, black-and-white perspective. In this flattened view, ribs shadow the lungs, and soft tissues blend into one another.
Historically, solving this issue meant attempting a process called dual-energy subtraction. This technique takes two separate X-ray exposures at different voltage levels to isolate dense materials like bones from soft structures like lung tissue. However, traditional dual-energy systems suffer from a critical flaw: patient movement. Because the two images are taken a split second apart, even a slight heartbeat, breath, or tremor creates blurring, known as a motion artifact.
Furthermore, these older dual-energy systems require specialized, high-cost X-ray machines and deliver an increased radiation dose to the patient. For vulnerable individuals, such as newborn babies in neonatal units or critically ill patients on ventilators, moving them to a dedicated radiology suite or exposing them to extra radiation is a dangerous proposition. The industry desperately needed a solution that could deliver CT-like tissue differentiation on a mobile, low-dose platform.
Bridging Executive Strategy and Academic Brilliance
The turning point came when Amol Karnick met Dr. Karim S. Karim, a professor from the University of Waterloo. At the time, Karnick was working as a healthcare executive-in-residence at Communitech, a prominent Canadian tech hub. Dr. Karim had spent years researching and developing novel X-ray circuits and imaging devices, accumulating an impressive portfolio of patents and publications. He had the groundbreaking physics, but he needed a strategic business partner to turn academic innovation into a viable commercial product.
Karnick brought exactly what was missing: more than twenty years of deep medical imaging industry experience. He entered the profession with a Bachelor of Applied Science (BASc) in Engineering from the University of Waterloo and a Master of Engineering (M.Eng.) in Electrical Engineering from McGill University. Karnick built a strong corporate and technical foundation by working with large original equipment manufacturers (OEMs) like GE Healthcare, and later transitioned into key startup leadership roles spanning sales, engineering, and operations at innovative firms like Ultrasonix, Sentinelle Medical, and Ventripoint.
Recognizing the immense potential in Dr. Karim’s research, the duo partnered alongside co-founder Sina Ghanbarzadeh to transition the technology out of the university walls, officially founding KA Imaging in 2015 with Karnick stepping in as President and CEO.
A Vision Rooted in Equitable Healthcare Access
Karnick’s dedication to this venture went beyond just an interest in deep-technology commercialization. Throughout his two decades in medical imaging, he saw firsthand the vast inequalities in global healthcare infrastructure. While top-tier urban hospitals have rapid access to advanced diagnostic machinery, rural communities, indigenous populations, and remote field clinics are frequently left with basic, decades-old imaging tools.
Karnick realized that if they could design a high-performance X-ray detector that worked with existing, legacy X-ray machines, they could instantly upgrade the diagnostic capabilities of underserved clinics worldwide. The motivation was clear: create a technology that requires no extra radiation, demands no alterations to a hospital’s existing workflow, and provides premium diagnostic clarity anywhere from a cutting-edge hospital room to a remote village.
The Birth of the Single-Exposure Revolution
With Karnick directing the business strategy and capital-raising efforts, KA Imaging focused its attention on creating a device that would change the market: an innovation named Reveal. Developed as a portable, flat-panel X-ray detector, Reveal utilizes a patented technology called SpectralDR.
Unlike traditional digital radiography or older dual-energy systems, SpectralDR uses a unique, triple-stacked detector layer design. When a single X-ray pulse passes through the patient, the stacked layers capture different energy bands simultaneously. This single-exposure method generates three distinct visual outputs at the exact same millisecond: a traditional digital radiography overview image, a soft-tissue-optimized image that highlights lung nodules and lesions without bone interference, and a bone-enhanced image that isolates fractures and foreign objects.
Because all three images are captured concurrently, motion artifacts are completely eliminated. The patient receives the exact same low radiation dose as a standard chest X-ray, but the clinician receives three distinct, crystal-clear visual perspectives. This allows doctors to easily spot hidden apical lesions, confirm the placement of delicate bedside tubes, or detect early signs of pneumonia without needing to order an expensive and time-consuming CT scan.
Navigating Scale-Up Hurdles and Regulatory Horizons
Building a deep-tech company from the ground up requires navigating intense financial and regulatory hurdles. After launching in 2015, scaling production and proving clinical efficacy required steady capital. Karnick proved adept at fundraising, steering the company through highly competitive funding environments. The firm secured high-profile global validation, finishing third on the global investment show Meet the Drapers, receiving a $250,000 investment, and placing second in The Pitch 2021.
A profound challenge and unexpected pivot arrived in 2020 with the onset of the COVID-19 pandemic. As a respiratory virus overwhelmed global healthcare systems, rapid and accurate lung imaging became a matter of life and death. Karnick quickly prioritized Reveal’s capabilities directly onto pulmonary triage, including the detection of pneumonia, collapsed lungs, and early-stage lung complications.
Navigating regulatory bodies during a global crisis required extreme precision. Under Karnick’s leadership, the company maintained a highly transparent relationship with regulators, securing critical clearances from the FDA and Health Canada, followed by European CE Mark approvals. This paved the way for the commercial deployment of the Reveal 35C detector and mobile variations like the Reveal Mobi Pro and Mobi Lite mobile X-ray systems, bringing advanced diagnostic power directly to the patient’s bedside.
Striking Global Success Beyond Clinical Walls
Under Karnick’s ongoing guidance, KA Imaging has evolved from a local Canadian startup into an internationally recognized deep-tech powerhouse. The company’s global reputation was firmly cemented by capturing first place in the highly competitive Digital Health Tech track at the EPIC 2025 competition in Hong Kong, highlighting the company’s readiness to scale across major international healthcare networks.
Furthermore, Karnick recognized that the ability to differentiate materials using a single X-ray exposure had immense value far beyond standard hospital environments. Today, the technology platform is being explored and diversified across multiple lucrative sectors:
Security and Defense (EOD): Utilizing portable spectral detectors, specialized teams can inspect suspicious packages in the field, instantly identifying hidden internal components, wiring, and layered hazardous materials.
Non-Destructive Testing (NDT) & Manufacturing: Manufacturing, electronics, and automotive sectors use the single-exposure platform to identify structural welds, internal cracks, and component integrity, such as enhancing quality control in EV battery manufacturing, without damaging the product.
Veterinary Medicine: Veterinarians utilize the technology to safely image exotic and domestic animals, where keeping a live subject perfectly still is notoriously difficult, making motion-free imaging a massive clinical advantage.
X-ray in Space: Pushing the absolute limits of physical design, KA Imaging has placed itself at the forefront of aerospace innovation. The company’s unique technology supported the first-ever medical X-ray imaging experiment conducted in space, proving how compact spectral systems can operate in microgravity to monitor astronaut bone health and hardware integrity.
Balancing Execution with Empowered Innovation
Karnick’s leadership philosophy balances deep technical accountability with an agile startup mindset. His professional mantra is simple: “Work hard, play hard.” Coming from an engineering background himself, he speaks the language of his research and development teams, fostering a culture where calculated risk-taking and scientific curiosity are highly encouraged.
At the same time, his extensive background with large original equipment manufacturers (OEMs) like GE Healthcare instills a strict corporate discipline regarding quality control, manufacturing standards, and regulatory compliance. Rather than micromanaging his multidisciplinary teams across sales, engineering, and operations, Karnick focuses on alignment. He sets a clear global vision and empowers his specialists to solve complex technical and commercial problems independently.
Redefining the Frontiers of Advanced Imaging
The future of imaging relies on making advanced data easy to use, highly portable, and universally accessible. As KA Imaging moves forward, the company is actively focused on scaling its operations, drawing strategic investments and commercial partnerships to fuel global distribution and expand its market footprint.
The ultimate goal under Karnick’s stewardship is to make single-exposure spectral imaging the baseline standard for radiography worldwide. By proving that advanced, material-differentiating X-rays can be deployed safely in any environment, from a rural field clinic in Kenya or a military checkpoint to a busy metropolitan ICU, KA Imaging is successfully removing the compromises from modern diagnostics. Guided by a blend of technical mastery and an emphasis on equitable global access, Amol Karnick is ensuring that the world sees healthcare through a much clearer lens.
